Central Apneas Due to the CLIFAHDD Syndrome Successfully Treated with Pyridostigmine
- PMID: 35055596
- PMCID: PMC8776169
- DOI: 10.3390/ijerph19020775
Central Apneas Due to the CLIFAHDD Syndrome Successfully Treated with Pyridostigmine
Abstract
NALCN mutations lead to complex neurodevelopmental syndromes, including infantile hypotonia with psychomotor retardation and characteristic facies (IHPRF) and congenital contractures of limbs and face, hypotonia, and developmental delay (CLIFAHDD), which are recessively and dominantly inherited, respectively. We present a patient in whom congenital myasthenic syndrome (CMS) was suspected due to the occurrence of hypotonia and apnea episodes requiring resuscitation. For this reason, treatment with pyridostigmine was introduced. After starting the treatment, a significant improvement was observed in reducing the apnea episodes and slight psychomotor progress. In the course of further diagnostics, CMS was excluded, and CLIFAHDD syndrome was confirmed. Thus, we try to explain a possible mechanism of clinical improvement after the introduction of treatment with pyridostigmine in a patient with a mutation in the NALCN gene.
Keywords: CLIFAHDD; NALCN; apnea; pyridostigmine.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Al-Sayed M.D., Al-Zaidan H., Albakheet A., Hakami H., Kenana R., Al-Yafee Y., Al-Dosary M., Qari A., Al-Sheddi T., Al-Muheiza M., et al. Mutations in NALCN Cause an Autosomal-Recessive Syndrome with Severe Hypotonia, Speech Impairment, and Cognitive Delay. Am. J. Hum. Genet. 2013;93:721–726. doi: 10.1016/j.ajhg.2013.08.001. - DOI - PMC - PubMed
-
- Chong J., McMillin M.J., Shively K.M., Beck A.E., Marvin C.T., Armenteros J.R., Buckingham K.J., Nkinsi N.T., Boyle E., Berry M.N., et al. De Novo Mutations in NALCN Cause a Syndrome Characterized by Congenital Contractures of the Limbs and Face, Hypotonia, and Developmental Delay. Am. J. Hum. Genet. 2015;96:462–473. doi: 10.1016/j.ajhg.2015.01.003. - DOI - PMC - PubMed
-
- Liu Z., Zhang L., Shen D., Ding C., Yang X., Zhang W., Li J., Deng J., Gong S., Liu J., et al. Compound Heterozygous CHAT Gene Mutations of a Large Deletion and a Missense Variant in a Chinese Patient With Severe Congenital Myasthenic Syndrome With Episodic Apnea. Front. Pharmacol. 2019;10:259. doi: 10.3389/fphar.2019.00259. - DOI - PMC - PubMed
-
- McMacken G., Whittaker R., Evangelista T., Abicht A., Dusl M., Lochmüller H. Congenital myasthenic syndrome with episodic apnoea: Clinical, neurophysiological and genetic features in the long-term follow-up of 19 patients. J. Neurol. 2017;265:194–203. doi: 10.1007/s00415-017-8689-3. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
